The Venture Codex Logo

The Venture Codex

Overview

Biopreservation media products and consulting for cells and tissues.

Founded

1987

Deals ยท 12mo

0

Stage focus

Series A

Geographic focus

United States

Sector focus

Biotechnology
Commercial
Dairy
Industrial
...

Investment portfolio

5rounds
NAMEDATESIZE
iVexSol
Jan 2023Participated
$24 MSeries A
iVexSol
Dec 2020Participated
$13 MSeries A
iVexSol
Oct 2019Led
$2 MOther Equity
Sexton Biotechnologies
Sep 2019Participated
$5 MOther Equity
Savsu Technologies
May 2018Led
$1 MOther Equity
iVexSol
Jan 2023Participated
$24 MSeries A
iVexSol
Dec 2020Participated
$13 MSeries A
iVexSol
Oct 2019Led
$2 MOther Equity
Sexton Biotechnologies
Sep 2019Participated
$5 MOther Equity
Savsu Technologies
May 2018Led
$1 MOther Equity
5
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

BioLife Solutions: 5 funding rounds are recorded in the selected participation categories.All available history.
BioLife Solutions: 5 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A02
Other Equity21

Monthly Deal Activity

BioLife Solutions: 5 deals are recorded across 102 months.All available history.
BioLife Solutions: 5 deals are recorded across 102 months. All available history
MonthDeals
May '181
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '191
Oct '191
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '201
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

BioLife Solutions: Manufacturing is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

BioLife Solutions: Manufacturing is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Manufacturing3
Hardware & Robotics1
Health & Life Sciences1
Professional Services1

Deal Size Distribution

BioLife Solutions: 5 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

BioLife Solutions: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M2
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

BioLife Solutions: United States has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

BioLife Solutions: United States has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
United States5
BioLife Solutions: 6 co-investors are shown, with Casdin Capital sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

BioLife Solutions: 6 co-investors are shown, with Casdin Capital sharing 4 recorded deals. All available history
Co-investorShared deals
Casdin Capital4
Asahi Kasei Medical1
BioCrossroads1
Bristol Myers Squibb1
Charles River Laboratories1
Cook Regentec1

Investment Strategy

BioLife Solutions: Led accounts for 40% and participating for 60% of round participation.All available history.
BioLife Solutions: Led accounts for 40% and participating for 60% of round participation. All available history
CategoryDeals (count)Share (%)
Led240%
Participating360%
BioLife Solutions: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
BioLife Solutions: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Aby Mathew

Senior Vice President and Chief Technology Officer

Anthony Davies

SAB member

Dusty Tenney

President and COO

Michael Rice

Chairman of the Board & CEO

Rod de Greef

President and COO